Westminster Health Forum

Next steps for combating antimicrobial resistance - funding, prevention and research priorities

Morning, Wednesday, 6th February 2019

Sixty One Whitehall, London SW1A 2ET

THIS EVENT IS CPD CERTIFIED



This timely conference focuses on latest developments in tackling antimicrobial resistance (AMR) in England.


It comes with the 2013-2018 UK AMR Strategy due to complete soon and with AMR cited by the Minister for Public Health as central to the forthcoming NHS Long Term Plan - with the plan set to focus on prevention, funding and research. With a refreshed AMR strategy expected to include a 20-year vision and 5-year action plans, the agenda looks at the way forward for delivery to ensure that key aims are met.


Planned sessions will look at the progress of research being conducted to strengthen efforts to tackle the spread of AMR and to develop new forms of treatment for drug resistant bacterial infections - including industry collaboration, funding for new medicines and the role of reimbursement models in encouraging drug development - as well as consideration of the next steps for diagnostics being utilised to identify drug-resistant bacteria and support treatment decisions.


Further sessions will focus on the impact of new sources of funding in bringing new solutions, with: 



Delegates will also examine the measures being taken by industry and healthcare professionals to encourage the responsible use of antibiotics in healthcare - with the need for responsible prescribing recently highlighted in the DHSC’s vision for prevention.


With the Veterinary Medicines Directorate reporting that sales of antibiotics for use in food-producing animals are at their lowest since 1993, the seminar includes focus on progress towards reducing the use of antibiotics within farming and agriculture, looking at potential ways forward for developing a holistic approach to human, animal and environmental health. 


There will also be discussion on the next steps for strengthening international collaboration on AMR, which is highlighted as a main strand of the UK biological security strategy - and follows £30m funding made available by the Government to support the global fight against AMR.



Guest of Honour

Professor Dame Sally Davies

Chief Medical Officer, Department of Health and Social Care (subject to diary)

Supported by

Guest of Honour

Professor Dame Sally Davies

Chief Medical Officer, Department of Health and Social Care (subject to diary)

Keynote Speakers

Dr Manica Balasegaram

Executive Director, Global Antibiotic Research and Development Partnership

Professor Alan Johnson

Head of Surveillance, Antimicrobial Resistance Division, National Infection Service, Public Health England

Chairs

Lord Trees

Co-Chair, All-Party Parliamentary Group on Antibiotics and Co-Chair, All-Party Parliamentary Group for Animal Welfare

Kevin Hollinrake MP

Co-Chair, All-Party Parliamentary Group on Antibiotics

Speakers

Gary Cohen

Vice-President, Global Health and President, BD Foundation

Pat Cattini

President, Infection Prevention Society

Dr Anita Sharma

GP and Clinical Director, Vascular and Medicine Optimisation, NHS Oldham Clinical Commissioning Group

Professor Hilary Thomas

Chief Medical Adviser and Member, Centre of Excellence in Healthcare and Life Sciences, KPMG

James Anderson

Chair, Antibiotic Network, ABPI and Head of Corporate Government Affairs, GSK

Richard Griffiths

Chief Executive, British Poultry Council

Professor Ian Feavers

Head of Bacteriology, NIBSC

Jonathan Pearce

Head of Infections and Immunity, Medical Research Council

Cóilín Nunan

Scientific Advisor, Alliance to Save our Antibiotics